These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31527453)

  • 21. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
    Vijayaraghavalu S; Labhasetwar V
    Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
    Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
    Chekhun VF; Borikun TV; Lukianova NY
    Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
    Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
    Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis.
    Chantarawong W; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
    Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30754694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100.
    Gökşen Tosun N
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3249-3259. PubMed ID: 37917369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
    Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
    Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro.
    Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
    Lee MG; Lee KS; Nam KS
    IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance.
    Luo F; Yang J; Yang X; Mi J; Ye T; Li G; Xie Y
    Phytomedicine; 2024 Oct; 133():155945. PubMed ID: 39146878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Original research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties.
    Ballazhi L; Imeri F; Jashari A; Popovski E; Stojković G; Dimovski AJ; Mikhova B; Mladenovska K
    Acta Pharm; 2017 Mar; 67(1):35-52. PubMed ID: 28231049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y; Liao X; Zhu L; Yang H
    J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics.
    Chekhun VF; Lukianova NY; Borikun TV; Zadvorny TV; Mokhir A
    Exp Oncol; 2017 Mar; 39(1):25-29. PubMed ID: 28361857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells.
    El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH
    DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells.
    Hong CE; Park AK; Lyu SY
    Mol Cell Biochem; 2014 Sep; 394(1-2):225-35. PubMed ID: 24878989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.